It's Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa

P Behzadi, Z Baráth, M Gajdács - Antibiotics, 2021 - mdpi.com
Pseudomonas aeruginosa is the most frequent cause of infection among non-fermenting
Gram-negative bacteria, predominantly affecting immunocompromised patients, but its …

[HTML][HTML] Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes

CY Wang, JS Jerng, KY Cheng, LN Lee, CJ Yu… - Clinical Microbiology …, 2006 - Elsevier
ABSTRACT Between 1 January 2003 and 31 December 2003, 37 patients had positive
cultures of pandrug-resistant Pseudomonas aeruginosa (PDRPA) resistant to all …

Clinical Prediction Tool To Identify Patients with Pseudomonas aeruginosa Respiratory Tract Infections at Greatest Risk for Multidrug Resistance

TP Lodise, CD Miller, J Graves, JP Furuno… - Antimicrobial agents …, 2007 - Am Soc Microbiol
Despite the increasing prevalence of multiple-drug-resistant (MDR) Pseudomonas
aeruginosa, the factors predictive of MDR have not been extensively explored. We sought to …

The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update

D Reynolds, M Kollef - Drugs, 2021 - Springer
Pseudomonas aeruginosa is a Gram-negative bacterial pathogen that is a common cause of
nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and …

Genetic diversity of clinical Pseudomonas aeruginosa isolates in a public hospital in Spain

M Gomila, M del Carmen Gallegos… - BMC microbiology, 2013 - Springer
Background Pseudomonas aeruginosa is an important nosocomial pathogen that exhibits
multiple resistances to antibiotics with increasing frequency, making patient treatment more …

Molecular Characterization of an Epidemic Clone of Panantibiotic-Resistant Pseudomonas aeruginosa

A Deplano, O Denis, L Poirel, D Hocquet… - Journal of clinical …, 2005 - Am Soc Microbiol
We describe the molecular characterization of a multiresistant Pseudomonas aeruginosa
clone causing an outbreak in the intensive care unit (ICU) of a tertiary-care university …

Sequence types 235, 111, and 132 predominate among multidrug-resistant Pseudomonas aeruginosa clinical isolates in Croatia

M Guzvinec, R Izdebski, I Butic, M Jelic… - Antimicrobial agents …, 2014 - Am Soc Microbiol
ABSTRACT A population analysis of 103 multidrug-resistant Pseudomonas aeruginosa
isolates from Croatian hospitals was performed. Twelve sequence types (STs) were …

[HTML][HTML] Pseudomonas aeruginosa resistente a antimicrobianos en hospitales colombianos

LM Villa, JA Cortés, AL Leal, A Meneses… - Revista chilena de …, 2013 - SciELO Chile
Introducción: Pseudomonas aeruginosa causa infecciones con altas tasas de morbilidad y
mortalidad. Objetivo: Conocer las tasas de resistencia de P. aeruginosa en instituciones …

Intraclonal variations of resistance and phenotype in Pseudomonas aeruginosa epidemic high-risk clone ST308: a key to success within a hospital?

F Abdouchakour, F Aujoulat, P Licznar-Fajardo… - International Journal of …, 2018 - Elsevier
Most multidrug-resistant (MDR) and extensively drug-resistant (XDR) P. aeruginosa strains
belonged to epidemic high-risk (EHR) clones that succeeded worldwide in the context of …

In vitro synergism of β-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa

K Kanellakopoulou, P Sarafis, I Galani… - International journal of …, 2008 - Elsevier
In vitro combinations of β-lactams with fluoroquinolones against multidrug-resistant (MDR)
Pseudomonas aeruginosa were tested. From a total of 200 isolates, 24 genetically distinct …